drugset / Trial / NCT03656393
To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma
Non-randomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to evaluate the efficacy and safety of targeted gefitinib versus oral vinorelbine and carboplatin in EGFR-mutant NSCLC patients.
Timeline
- Start
- 2018-08-31
- Primary completion
- 2020-07-31
- Completion
- 2020-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carboplatin | Small molecule | 5 unknown | Intravenous |
| Subject | Gefitinib | Small molecule | 250 mg | Oral |
| Comparator | Vinorelbine | Small molecule | 60 mg/m2 | Oral |